# MetaVia Inc.: filings

MTVA · Nasdaq · CIK 1638287 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtva.md) · [Financials](/companies/mtva/financials.md) · [Filings](/companies/mtva/filings.md) · [Insiders](/companies/mtva/insiders.md)

## Reports and events: 274 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 183, 4 116, 3 34, CORRESP 32, 10-Q 31, UPLOAD 21, 424B3 16, EFFECT 16, SC 13D/A 14, SC 13G 13, DEF 14A 12, 425 11, S-8 11, 10-K 10, D 9, SC 13G/A 8, 424B5 7, PRE 14A 7, S-3 7, 8-K/A 6, S-1 5, S-1/A 5, SC 13D 5, ARS 4, D/A 4, 424B4 3, 4/A 3, FWP 3, POS AM 3, S-4/A 3, 10-K/A 2, 3/A 2, CT ORDER 2, DRS 2, DRSLTR 2, PRER14A 2, SCHEDULE 13G 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 8-A12B 1, CERTNAS 1, DEFA14A 1, DRS/A 1, NT 10-K 1, NT 10-Q 1, S-1MEF 1, S-4 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 09:01 ET | [8-K](/filings/0001104659-26-119401.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-119401 |
| 2026-10-13 | 08:35 ET | [8-K](/filings/0001104659-26-115300.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115300 |
| 2026-09-09 | 09:00 ET | [8-K](/filings/0001104659-26-106156.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-106156 |
| 2026-08-06 | 16:26 ET | [10-Q](/filings/0001104659-26-092051.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092051 |
| 2026-08-06 | 16:05 ET | [8-K](/filings/0001104659-26-091981.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-091981 |
| 2026-07-09 | 08:35 ET | [8-K](/filings/0001104659-26-082116.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-082116 |
| 2026-07-02 | 16:06 ET | [8-K](/filings/0001104659-26-080316.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-080316 |
| 2026-06-08 | 16:00 ET | [8-K](/filings/0001104659-26-071358.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-071358 |
| 2026-06-08 | 09:01 ET | [8-K](/filings/0001104659-26-071211.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-071211 |
| 2026-05-27 | 09:01 ET | [8-K](/filings/0001104659-26-066631.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-066631 |
| 2026-05-18 | 09:01 ET | [8-K](/filings/0001104659-26-063059.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-063059 |
| 2026-05-14 | 16:07 ET | [10-Q](/filings/0001104659-26-061166.md) | Quarterly report, period 2026-03-31 | 0001104659-26-061166 |
| 2026-05-14 | 16:06 ET | [8-K](/filings/0001104659-26-061148.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-061148 |
| 2026-05-11 | 09:01 ET | [8-K](/filings/0001104659-26-058332.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-058332 |
| 2026-04-27 | 06:02 ET | [DEF 14A](/filings/0001140361-26-016802.md) | Proxy statement, period 2026-06-08 | 0001140361-26-016802 |
| 2026-04-10 | 08:45 ET | [8-K](/filings/0001104659-26-041784.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-041784 |
| 2026-03-26 | 16:30 ET | [8-K](/filings/0001104659-26-035238.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-035238 |
| 2026-03-26 | 08:45 ET | [10-K](/filings/0001104659-26-034911.md) | Annual report, period 2025-12-31 | 0001104659-26-034911 |
| 2026-03-26 | 08:31 ET | [8-K](/filings/0001104659-26-034907.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-034907 |
| 2026-03-18 | 08:05 ET | [8-K](/filings/0001104659-26-029912.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-029912 |
| 2026-01-27 | 16:01 ET | [8-K](/filings/0001104659-26-006976.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-006976 |
| 2026-01-16 | 16:05 ET | [8-K](/filings/0001104659-26-004532.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-004532 |
| 2026-01-12 | 17:22 ET | [S-1/A](/filings/0001104659-26-002930.md) | Registration statement, amended | 0001104659-26-002930 |
| 2026-01-05 | 17:22 ET | [8-K](/filings/0001104659-26-000736.md) | 2.02 Results of operations | 0001104659-26-000736 |
| 2026-01-05 | 17:04 ET | [S-1](/filings/0001104659-26-000695.md) | Registration statement | 0001104659-26-000695 |
| 2026-01-05 | 08:32 ET | [8-K](/filings/0001104659-26-000432.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-000432 |
| 2025-12-19 | 16:01 ET | [8-K](/filings/0001104659-25-123099.md) | 8.01 Other events | 0001104659-25-123099 |
| 2025-12-02 | 08:46 ET | [8-K](/filings/0001104659-25-117540.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-117540 |
| 2025-11-26 | 16:29 ET | [8-K](/filings/0001104659-25-116456.md) | 3.01 Delisting notice | 0001104659-25-116456 |
| 2025-11-07 | 09:01 ET | [8-K](/filings/0001104659-25-108179.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-108179 |
| 2025-11-06 | 16:31 ET | [8-K](/filings/0001104659-25-107790.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-107790 |
| 2025-11-06 | 16:07 ET | [10-Q](/filings/0001104659-25-107726.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107726 |
| 2025-11-06 | 08:31 ET | [8-K](/filings/0001104659-25-107447.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107447 |
| 2025-08-07 | 16:30 ET | [8-K](/filings/0001558370-25-010787.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-010787 |
| 2025-08-07 | 16:06 ET | [10-Q](/filings/0001558370-25-010759.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010759 |
| 2025-08-07 | 08:31 ET | [8-K](/filings/0001558370-25-010658.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010658 |
| 2025-08-06 | 09:01 ET | [8-K](/filings/0001558370-25-010415.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-010415 |
| 2025-08-04 | 08:46 ET | [8-K](/filings/0001558370-25-010031.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-010031 |
| 2025-07-09 | 09:00 ET | [8-K](/filings/0001558370-25-009139.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-009139 |
| 2025-06-30 | 16:05 ET | [8-K](/filings/0001558370-25-009000.md) | 5.07 Shareholder vote results | 0001558370-25-009000 |
| 2025-06-10 | 18:22 ET | [DEF 14A](/filings/0001140361-25-021981.md) | Proxy statement, period 2025-06-30 | 0001140361-25-021981 |
| 2025-05-30 | 17:06 ET | [8-K](/filings/0001104659-25-054976.md) | 3.01 Delisting notice | 0001104659-25-054976 |
| 2025-05-21 | 08:30 ET | [8-K](/filings/0001558370-25-008047.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-008047 |
| 2025-05-20 | 16:15 ET | [SCHEDULE 13D/A](/filings/0000899140-25-000717.md) | Ownership report, active investor, amended | 0000899140-25-000717 |
| 2025-05-14 | 16:10 ET | [10-Q](/filings/0001558370-25-007749.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007749 |
| 2025-05-14 | 16:05 ET | [8-K](/filings/0001558370-25-007740.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007740 |
| 2025-05-14 | 09:03 ET | [8-K](/filings/0001104659-25-048210.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-048210 |
| 2025-05-07 | 07:00 ET | [8-K](/filings/0001558370-25-006598.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-006598 |
| 2025-04-22 | 08:33 ET | [8-K](/filings/0001558370-25-005113.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-005113 |
| 2025-04-15 | 16:15 ET | [8-K](/filings/0001558370-25-004833.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-004833 |

Page 1 of 6. [Older](/companies/mtva/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 09:02 ET. No prices; not investment advice.